Healthcare venture capital firm Third Rock Ventures said today that it closed a new $770 million “Fund V” looking to invest in early-stage and start-up companies. With the newly closed fund, the Boston-based VC fund said it will continue to search for and help launch innovative life science companies “that have the potential to transform the […]
Healthcare venture capital firm Third Rock Ventures said today it raised $616 million for its new oversubscribed Fund IV, which will support innovative healthcare companies. The new investment round brings the total funding raised by the Boston-based venture capital firm to $1.9 billion, the group said. “We appreciate the ongoing support from all the investors […]
Bay State startup DC Device announced the successful close of a $34 million Series D financing round, hoping to use the funds to advance clinical evaluation of its InterAtrial Shunt Device.
The company aims to market the world’s 1st minimally invasive device for treating diastolic heart failure, a market worth a potential $5 billion globally, according to a DC Device press release.
March 24, 2014 by Arezu Sarvestani
Massachusetts-based NinePoint Medical Imaging closed a $34 million Series B funding round, the company announced today.
NinePoint plans to use the funds to support ongoing U.S. commercial efforts for its NvisionVLE system, which provides high-res, endoscopic imaging of organs and tissues. The system can provide cross-sectional, volumetric views of organs, including tissues below the surface, the company said.
Third Rock Ventures, one of the premiere healthcare venture capital firms, is loaded for bear again.
The Boston-based VC group recently closed its 3rd fund, a $516 million tranche that will go towards launching some 15 to16 new life science companies in the coming months. In the past 6 years Third Rock Ventures has raised more than $1.3 billion and launched some 31 companies across the life sciences spectrum.
Massachusetts-based medical device startup DC Devices closed a $10.7 million funding round in support of its minimally invasive treatment for heart failure.
DC Devices "seeks to become the leading medical device company for the treatment of congestive heart failure," according to its page on the website of venture capital firm General Catalyst.
Boston investment firm Third Rock Ventures LLC has raised $426 million for its second (oversubscribed) fund and is opening a San Francisco office to continue its practice of "launching and supporting transformative life sciences companies."